Mometasone furoate

莫米松糠酸酯

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameMometasone furoate
Drug Alias Name糠酸莫米松Mometasonum糠莫米松Mometasonamometasone +[24] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)SneezingInflammation +[21] 
Global Approved IndicationsPruritusEczemaDermatitis +[4] 
Approved Indications in ChinaEczemaDermatitis
Original Approved Country/TerritoryUnited States
Original Approved Date1987/04/30
Country/TerritoryBelgiumBulgariaCanada +[34] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesBiofrontera Pharma GmbhSchering - Plough SaNational Heart, Lung, And Blood Institute (Nhlbi) +[9] 
Inactive CompaniesSandozActavis IncBenha University +[17] 
Active IndicationsEczemaDermatitisAnemia, Sickle Cell +[9] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)SneezingInflammation +[12] 

Other Information

ATC CodeD07AC13D07XC03R01AD09 +[4] 
Related LinksWikipediaDrugBankKEGG